Stock listing
HCWB Stock Price, News, Filings & Events — Hcw Biologics Inc.
Selected listing: HCWB · BOATS · USD · US
This page tracks Hcw Biologics Inc.'s HCWB:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following HCWB:BOATS. HCWB:BOATS is the stock-level entry point for investors researching Hcw Biologics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Hcw Biologics Inc. is a public company traded under the ticker HCWB in the American market. The company has a market cap of approximately $6.39 million. Hcw Biologics focuses on developing innovative biologic therapies.
- Ticker
- HCWB:BOATS
- Asset type
- Stock
- Market cap
- $5.0M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
Hcw Biologics Inc. HCWB:BOATS stock context
This page tracks Hcw Biologics Inc.'s HCWB:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following HCWB:BOATS. HCWB:BOATS is the stock-level entry point for investors researching Hcw Biologics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Hcw Biologics Inc. is a public company traded under the ticker HCWB in the American market. The company has a market cap of approximately $6.39 million. Hcw Biologics focuses on developing innovative biologic therapies.
Latest news from Hcw Biologics Inc.
HCW Biologics Reports Second Quarter 2026 Business and Clinical Development Highlights and Financial Results
August 17, 2026
HCW Biologics Inc. Announces Pricing of $1.6 Million Private Placement Offering
July 29, 2026
HCW Biologics Reaches Milestones for Its Proprietary Tetravalent Second-Generation T-Cell Engager Program On Track To Initiate Clinical T...
July 23, 2026
HCW Biologics Regained Compliance with Bid Price Rule Per Nasdaq Compliance Letter
June 30, 2026
HCW Biologics Announces 1-for-6 Reverse Stock Split Effective on June 30, 2026
June 26, 2026
Research Hcw Biologics Inc.
Hcw Biologics Inc. investor report
Review AI stock analysis and investor report context for HCWB:BOATS.
Hcw Biologics Inc. company profile
View the public company page for Hcw Biologics Inc. on 6ix.
Hcw Biologics Inc. news
Read company news and market updates connected to Hcw Biologics Inc..
Hcw Biologics Inc. investor events
Find investor webinars, events, and replay context for Hcw Biologics Inc..